Insider Transactions in Q1 2025 at Alkermes Plc. (ALKS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Open market or private sale
|
Direct |
1,938
-20.07%
|
$65,892
$34.0 P/Share
|
|
Feb 26
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,494
-1.66%
|
$84,796
$34.8 P/Share
|
|
Feb 26
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,617
+3.59%
|
-
|
|
Feb 26
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,049
-1.47%
|
$103,666
$34.8 P/Share
|
|
Feb 26
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,866
+3.21%
|
-
|
|
Feb 26
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,049
-3.77%
|
$103,666
$34.8 P/Share
|
|
Feb 26
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,866
+7.83%
|
-
|
|
Feb 26
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,695
-1.8%
|
$125,630
$34.8 P/Share
|
|
Feb 26
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,322
+3.9%
|
-
|
|
Feb 26
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,402
-2.52%
|
$81,668
$34.8 P/Share
|
|
Feb 26
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,409
+5.37%
|
-
|
|
Feb 26
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
808
-7.72%
|
$27,472
$34.8 P/Share
|
|
Feb 26
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,746
+20.79%
|
-
|
|
Feb 25
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Open market or private sale
|
Direct |
3,743
-32.66%
|
$131,005
$35.26 P/Share
|
|
Feb 23
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-4.41%
|
$119,490
$35.32 P/Share
|
|
Feb 23
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,689
+9.04%
|
-
|
|
Feb 23
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,846
-3.07%
|
$99,610
$35.32 P/Share
|
|
Feb 23
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+6.46%
|
-
|
|
Feb 23
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,587
-1.75%
|
$90,545
$35.32 P/Share
|
|
Feb 23
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,825
+3.8%
|
-
|
|
Feb 23
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
672
-5.54%
|
$23,520
$35.32 P/Share
|
|
Feb 23
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,284
+15.84%
|
-
|
|
Feb 23
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,880
-1.93%
|
$135,800
$35.32 P/Share
|
|
Feb 23
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,738
+4.17%
|
-
|
|
Feb 23
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-1.67%
|
$119,490
$35.32 P/Share
|
|
Feb 23
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,689
+3.63%
|
-
|
|
Feb 22
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,452
-7.26%
|
$190,820
$35.32 P/Share
|
|
Feb 22
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,279
+14.05%
|
-
|
|
Feb 22
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,157
-3.53%
|
$110,495
$35.32 P/Share
|
|
Feb 22
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,109
+7.36%
|
-
|
|
Feb 22
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,154
-2.18%
|
$110,390
$35.32 P/Share
|
|
Feb 22
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,109
+4.67%
|
-
|
|
Feb 22
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
983
-9.08%
|
$34,405
$35.32 P/Share
|
|
Feb 22
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
3,114
+22.33%
|
-
|
|
Feb 22
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,305
-2.19%
|
$150,675
$35.32 P/Share
|
|
Feb 22
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,694
+4.71%
|
-
|
|
Feb 22
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,300
-1.65%
|
$115,500
$35.32 P/Share
|
|
Feb 22
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,432
+3.59%
|
-
|
|
Feb 20
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Open market or private sale
|
Direct |
1,327
-14.67%
|
$46,445
$35.69 P/Share
|
|
Feb 18
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,950
-2.07%
|
$138,250
$35.9 P/Share
|
|
Feb 18
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,896
+4.46%
|
-
|
|
Feb 18
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,869
-1.34%
|
$65,415
$35.9 P/Share
|
|
Feb 18
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,354
+4.35%
|
-
|
|
Feb 18
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,822
-1.45%
|
$98,770
$35.9 P/Share
|
|
Feb 18
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,354
+3.16%
|
-
|
|
Feb 18
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,869
-2.22%
|
$65,415
$35.9 P/Share
|
|
Feb 18
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,354
+7.02%
|
-
|
|
Feb 18
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
706
-7.24%
|
$24,710
$35.9 P/Share
|
|
Feb 18
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,033
+17.25%
|
-
|
|
Feb 18
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,950
-5.92%
|
$138,250
$35.9 P/Share
|